{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:56:14Z","timestamp":1790866574594,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ30039"],"award-info":[{"award-number":["2025JJ30039"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073096"],"award-info":[{"award-number":["82073096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016104","name":"Key Project of Research and Development Plan of Hunan Province","doi-asserted-by":"publisher","award":["2024DK2006"],"award-info":[{"award-number":["2024DK2006"]}],"id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189721","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:21:09Z","timestamp":1790576469000},"page":"189721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macrophage-mesenchymal crosstalk in recurrent glioblastoma: a perspective for therapeutic strategies"],"prefix":"10.1016","volume":"1881","author":[{"given":"Jianyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouxi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189721_bb0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13073-025-01553-2","article-title":"Spatial-reprogramming derived GPNMB+ macrophages interact with COL6A3+ fibroblasts to enhance vascular fibrosis in glioblastoma","volume":"17","author":"Du","year":"2025","journal-title":"Genome Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0010","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.3390\/ijms25126733","article-title":"Recurrent glioblastoma\u2014molecular underpinnings and evolving treatment paradigms","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0015","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/jpm14050538","article-title":"Preferred imaging for target volume delineation for radiotherapy of recurrent glioblastoma: a literature review of the available evidence","volume":"14","author":"Cuccia","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/OTT.S366371","article-title":"Recurrent glioblastoma: ongoing clinical challenges and future prospects","volume":"16","author":"Pineda","year":"2023","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbcan.2026.189721_bb0025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/cancers16071276","article-title":"Immunotherapeutic strategies for the treatment of glioblastoma: current challenges and future perspectives","volume":"16","author":"Salvato","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0030","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.3390\/cancers15174308","article-title":"The development of immunotherapy for the treatment of recurrent glioblastoma","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0035","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3390\/cancers16193283","article-title":"Unveiling the inflammatory landscape of recurrent glioblastoma through histological-based assessments","volume":"16","author":"Dadario","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0040","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41467-023-38186-1","article-title":"Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states","volume":"14","author":"Al-Dalahmah","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0045","series-title":"New Insights into Monocyte-Derived Macrophages in Glioblastoma, Research","first-page":"0836","volume":"8","author":"Li","year":"2026"},{"key":"10.1016\/j.bbcan.2026.189721_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101114","article-title":"Cancer plasticity in therapy resistance: mechanisms and novel strategies","volume":"76","author":"Niu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189721_bb0055","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.celrep.2017.05.040","article-title":"MicroRNA-mediated dynamic bidirectional shift between the subclasses of glioblastoma stem-like cells","volume":"19","author":"Rooj","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189721_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.696","article-title":"Spatial omics: navigating to the golden era of cancer research","volume":"12","author":"Wu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41418-018-0248-7","article-title":"The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1","volume":"26","author":"Narayanan","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189721_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ccr.2014.06.005","article-title":"Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma","volume":"26","author":"Ozawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189721_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-025-05090-1","article-title":"The oncogenic role of CCDC34 in lower-grade gliomas: prognostic significance and therapeutic potential","volume":"175","author":"Shen","year":"2025","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10555-022-10051-5","article-title":"The multifaceted mechanisms of malignant glioblastoma progression and clinical implications","volume":"41","author":"Sun","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189721_bb0115","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fimmu.2018.01004","article-title":"Immune microenvironment in glioblastoma subtypes","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/ijms21030689","article-title":"Revealing and harnessing tumour-associated microglia\/macrophage heterogeneity in glioblastoma","volume":"21","author":"Pires-Afonso","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0125","article-title":"The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163451","article-title":"Monocyte-neutrophil entanglement in glioblastoma","volume":"133","author":"Friedmann-Morvinski","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189721_bb0140","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/cancers13143636","article-title":"Comparing tumor cell invasion and myeloid cell composition in compatible primary and relapsing glioblastoma","volume":"13","author":"Zhao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41568-021-00397-3","article-title":"Glial and myeloid heterogeneity in the brain tumour microenvironment","volume":"21","author":"Andersen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189721_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101329","article-title":"Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma","volume":"84","author":"Gao","year":"2026","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189721_bb0155","first-page":"74","article-title":"Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies","volume":"12","author":"Rapisarda","year":"2009","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.bbcan.2026.189721_bb0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/cancers15051519","article-title":"Metabolic barriers to glioblastoma immunotherapy","volume":"15","author":"Choudhary","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.976356","article-title":"A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas","volume":"13","author":"Ren","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2026.189721_bb0170","series-title":"TAMI-57. Induction of Ferroptosis Promotes Immunogenic Cell Death and Activation of the Immune Microenvironment in Glioma","author":"Argenziano","year":"2026"},{"key":"10.1016\/j.bbcan.2026.189721_bb0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0271678X19827885","article-title":"Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans","volume":"40","author":"Stadlbauer","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbcan.2026.189721_bb0180","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.3390\/ijms222212608","article-title":"Hypoxia: the cornerstone of glioblastoma","volume":"22","author":"Dom\u00e8nech","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0185","doi-asserted-by":"crossref","first-page":"11180","DOI":"10.3390\/ijms222011180","article-title":"Tumor-associated microglia\/macrophages as a predictor for survival in glioblastoma and temozolomide-induced changes in CXCR2 signaling with new resistance overcoming strategy by combination therapy","volume":"22","author":"Urbantat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10555-019-09792-7","article-title":"Causes, consequences, and therapy of tumors acidosis","volume":"38","author":"Pillai","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189721_bb0195","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/cancers12113244","article-title":"Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment","volume":"12","author":"P\u00e9rez-Tom\u00e1s","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0200","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3390\/ijms20112746","article-title":"Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma","volume":"20","author":"Fedele","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002015","article-title":"Mesenchymal transformation: the Rosetta stone of glioblastoma pathogenesis and therapy resistance","volume":"7","author":"Azam","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0210","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41418-018-0126-3","article-title":"TP53 gain-of-function mutation promotes inflammation in glioblastoma","volume":"26","author":"Ham","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189721_bb0220","article-title":"Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+\/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner","volume":"13","author":"Takacs","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0225","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2011.128","article-title":"Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model","volume":"92","author":"Wang","year":"2012","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0235","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ajpath.2017.04.020","article-title":"Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) inhibition interferes with anti\u2013vascular endothelial growth factor therapy\u2013induced glioma dissemination","volume":"187","author":"Gagner","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0245","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.18632\/oncotarget.2443","article-title":"Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma","volume":"5","author":"Barone","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189721_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000516780","article-title":"Metabolic regulation of macrophage activation","volume":"14","author":"Kolliniati","year":"2022","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0260","author":"Normalizing Function of Tumor Vessels"},{"key":"10.1016\/j.bbcan.2026.189721_bb0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"10.1016\/j.bbcan.2026.189721_bb0270","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189721_bb0275","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.yexcr.2013.03.025","article-title":"On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment","volume":"319","author":"Eibinger","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100985","article-title":"Advancing glioblastoma treatment by targeting metabolism","volume":"51","author":"Zhao","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189721_bb0285","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7150\/jca.63609","article-title":"Cholesterol metabolism and its implication in glioblastoma therapy","volume":"13","author":"Guo","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189721_bb0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0295","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2147\/IJN.S450853","article-title":"Nanoparticle-based combinational strategies for overcoming the blood-brain barrier and blood-tumor barrier","volume":"19","author":"Lim","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2026.189721_bb0300","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2741\/3726","article-title":"Tight junctions in cancer metastasis","volume":"16","author":"Martin","year":"2011","journal-title":"Front. Biosci.-Landmark"},{"key":"10.1016\/j.bbcan.2026.189721_bb0305","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1007\/s11033-023-08419-z","article-title":"Transforming growth factor \u03b2 (TGF-\u03b2) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches","volume":"50","author":"Esmaeilzadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbcan.2026.189721_bb0310","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3390\/cancers14133128","article-title":"Dynamic interactions between tumor cells and brain microvascular endothelial cells in glioblastoma","volume":"14","author":"Testa","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8373","article-title":"Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro","volume":"48","author":"Urbantat","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189721_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045562","article-title":"Glioblastoma cell-secreted Interleukin-8 induces brain endothelial cell permeability via CXCR2","volume":"7","author":"Dwyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189721_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2023.104595","article-title":"Low postoperative perfused vessel density is associated with increased soluble endothelial cell adhesion molecules during circulatory shock after cardiac surgery","volume":"150","author":"Greenwood","year":"2023","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0330","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1111\/cns.14269","article-title":"scRNA-seq and proteomics reveal the distinction of M2-like macrophages between primary and recurrent malignant glioma and its critical role in the recurrence","volume":"29","author":"You","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbcan.2026.189721_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1117466","article-title":"An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: a first-in-man clinical trial","volume":"14","author":"Grauslund","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.04.074","article-title":"Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy","volume":"28","author":"Chhabra","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.bbcan.2026.189721_bb0345","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189721_bb0350","series-title":"Spatial Patterning and Immunosuppression of Glioblastoma Immune Contexture in Hypoxic Niches","author":"Sattiraju","year":"2022"},{"key":"10.1016\/j.bbcan.2026.189721_bb0355","article-title":"Single-cell transcriptomics revealed subtype-specific tumor immune microenvironments in human glioblastomas","volume":"13","author":"Xiao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0360","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189721_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade3559","article-title":"TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189721_bb0370","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0375","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1535-7163.MCT-14-0011","article-title":"Temozolomide induces the production of epidermal growth factor to regulate MDR1 expression in glioblastoma cells","volume":"13","author":"Munoz","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189721_bb0380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189721_bb0385","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.18632\/oncotarget.1793","article-title":"MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme","volume":"5","author":"Knubel","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189721_bb0390","doi-asserted-by":"crossref","first-page":"v449","DOI":"10.1093\/neuonc\/noaf201.1783","article-title":"Glioblastoma-derived ribosomal protein S19 exacerbates cerebral edema through C5AR1 in tumor-associated macrophages","volume":"27","author":"Liu","year":"2025","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0395","article-title":"Recent advances in nanoenzymes based therapies for glioblastoma: overcoming barriers and enhancing targeted treatment","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.bbcan.2026.189721_bb0400","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/cancers11121989","article-title":"Exploiting current understanding of hypoxia mediated tumour progression for nanotherapeutic development","volume":"11","author":"Feng","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0405","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12672-024-00963-9","article-title":"Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2","volume":"15","author":"Li","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0410","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.3390\/ijms231911789","article-title":"Hypoxia-regulated tumor-derived exosomes and tumor progression: a focus on immune evasion","volume":"23","author":"Shao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0415","doi-asserted-by":"crossref","first-page":"21721","DOI":"10.1038\/s41598-025-05994-y","article-title":"THSG counteracts microglial glycolytic reprogramming and neuronal necroptosis both in vivo and in vitro under conditions of neuroinflammation","volume":"15","author":"Guo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189721_bb0420","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1700600114","article-title":"Metabolic origins of spatial organization in the tumor microenvironment","volume":"114","author":"Carmona-Fontaine","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189721_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-13-1196","article-title":"Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population","volume":"74","author":"Laoui","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0430","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189721_bb0435","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40170-023-00328-w","article-title":"A HIF-1\u03b1 inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells","volume":"11","author":"Matsufuji","year":"2023","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbcan.2026.189721_bb0440","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0445","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1111\/cas.14616","article-title":"Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer","volume":"111","author":"Luo","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0450","series-title":"Treatment Resistant Persister Cells Exploit Macrophage Lipid Metabolism to Sustain Glioblastoma Growth","author":"Chakraborty","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189721_bb0455","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41401-022-00984-6","article-title":"Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide","volume":"44","author":"Choo","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2026.189721_bb0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2017.05.023","article-title":"Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation","volume":"488","author":"Siqingaowa","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0465","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noab196.410","article-title":"IMMU-51. Single-cell analysis of tumor-associated microglia and macrophages from human glioblastoma","volume":"23","author":"Anand","year":"2021","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0470","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189721_bb0475","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.0308102100","article-title":"STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells","volume":"101","author":"Khodarev","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189721_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002115","article-title":"MUC1-C integrates activation of the IFN-\u03b3 pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer","volume":"9","author":"Yamashita","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189721_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114289","article-title":"Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity","volume":"43","author":"Purbey","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189721_bb0490","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae165.0663","article-title":"IMMU-72. Type I interferon signaling within glioblastoma cells promotes T-Cell exhaustion and resistance to checkpoint inhibitors","volume":"26","author":"Jackson","year":"2024","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0495","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11515-010-0034-5","article-title":"Regulation of phagocytosis by TAM receptors and their ligands","volume":"5","author":"Qingxian","year":"2010","journal-title":"Front. Biol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20507","article-title":"Don\u2019t eat me\/eat me signals as a novel strategy in cancer immunotherapy","volume":"9","author":"Khalaji","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2026.189721_bb0505","doi-asserted-by":"crossref","first-page":"12509","DOI":"10.18632\/oncotarget.2997","article-title":"Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype","volume":"5","author":"Xiang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189721_bb0510","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41467-023-37361-8","article-title":"Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0515","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251316604","article-title":"Macrophage polarisation in the tumour microenvironment: recent research advances and therapeutic potential of different macrophage reprogramming","volume":"32","author":"Guo","year":"2025","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbcan.2026.189721_bb0520","first-page":"99","article-title":"Phenomena and signaling mechanisms of macrophage reprogramming","volume":"59","author":"Malyshev","year":"2015","journal-title":"Patol. Fiziol. Eksp. Ter."},{"key":"10.1016\/j.bbcan.2026.189721_bb0525","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jcmm.13334","article-title":"Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-\u03baB and TGF-\u03b2 pathways","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0530","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/cancers5041456","article-title":"Bevacizumab for glioblastoma-a promising drug or not?","volume":"5","author":"Nagane","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189721_bb0535","doi-asserted-by":"crossref","unstructured":"X. Long, Y. Du, Y. Li, F. Guan, S. Wang, M. Huang, M. Wu, The double-positive cells in the tumor microenvironment, J. Transl. Intern. Med. 14 (n.d.) 14\u201333. doi:https:\/\/doi.org\/10.1515\/jtim-2026-0002.","DOI":"10.1515\/jtim-2026-0002"},{"key":"10.1016\/j.bbcan.2026.189721_bb0540","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","article-title":"Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression","volume":"11","author":"Yee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189721_bb0545","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41420-023-01507-w","article-title":"STAT3 and HIF1\u03b1 cooperatively mediate the transcriptional and physiological responses to hypoxia","volume":"9","author":"Dinarello","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189721_bb0550","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189721_bb0555","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-026-02672-x","article-title":"Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances","volume":"11","author":"Fang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189721_bb0560","article-title":"ME2 promotes proneural\u2013mesenchymal transition and lipogenesis in glioblastoma","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0565","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/biomedicines10081943","article-title":"Lipid metabolism in glioblastoma: from de novo synthesis to storage","volume":"10","author":"Kou","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189721_bb0570","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.3390\/ijms232213818","article-title":"Targeting oncogenic rewiring of lipid metabolism for glioblastoma treatment","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0575","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jare.2025.05.032","article-title":"Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis","volume":"80","author":"Gao","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70018","article-title":"Advances in cellular immune theranostic approaches for glioblastoma: current trends and future directions","volume":"4","author":"Gong","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.bbcan.2026.189721_bb0585","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e13525","article-title":"BBI608-201GBM: a phase Ib\/II clinical study of napabucasin (BBI608) in combination with temozolomide (TMZ) for adult patients with recurrent glioblastoma (GBM)","author":"Mason","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0590","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/neuonc\/nov299","article-title":"Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier","volume":"18","author":"Di","year":"2016","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0595","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.2068","article-title":"A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB)","author":"Thomas","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0600","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1200\/JCO.2024.42.16_suppl.2075","article-title":"A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma","volume":"42","author":"Cao","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0605","article-title":"Phase 1b\/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma","volume":"6","author":"Mendez","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.bbcan.2026.189721_bb0610","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s40265-019-01210-0","article-title":"Pexidartinib: first approval","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bbcan.2026.189721_bb0615","series-title":"Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study | Investigational New Drugs |","year":"2026"},{"key":"10.1016\/j.bbcan.2026.189721_bb0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(96)85017-6","article-title":"Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I\/II clinical trials on human cerebral gliomas","volume":"35","author":"Mohanti","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2026.189721_bb0625","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1593\/neo.04133","article-title":"Lonidamine causes inhibition of angiogenesis-related endothelial cell functions","volume":"6","author":"Del Bufalo","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189721_bb0630","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.18632\/oncotarget.26733","article-title":"Statins affect human glioblastoma and other cancers through TGF-\u03b2 inhibition","volume":"10","author":"Xiao","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189721_bb0635","doi-asserted-by":"crossref","DOI":"10.31083\/FBL41097","article-title":"Innate priming and tumor-associated macrophage reprogramming: a commentary on emerging immunotherapeutic strategies","volume":"30","author":"Balkhi","year":"2025","journal-title":"Front. Biosci.-Landmark"},{"key":"10.1016\/j.bbcan.2026.189721_bb0640","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF1R inhibition in gliomas","volume":"352","author":"Quail","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189721_bb0645","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1002\/ptr.8328","article-title":"Procyanidin B1 promotes PSMC3-NRF2 ubiquitination to induce ferroptosis in glioblastoma","volume":"38","author":"Gao","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0650","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1515\/jtim-2025-0059","article-title":"Metabolic reprogramming in neurodegenerative diseases: new insights into mTOR-mediated microglial polarization","volume":"13","author":"Song","year":"2025","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0655","doi-asserted-by":"crossref","first-page":"0912","DOI":"10.34133\/research.0912","article-title":"Mitochondria metabolism regulates glucose\u2013lipid homeostasis in neurodegenerative diseases","volume":"8","author":"Huang","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.bbcan.2026.189721_bb0660","article-title":"A functional nanocomposite tri-activates cuproptosis, ferroptosis, and mitophagy death pathway to oppose malignancies","author":"Deng","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbcan.2026.189721_bb0665","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175127","article-title":"Breaking the feed forward inflammatory cytokine loop in the tumor microenvironment of PDGFB-driven glioblastomas","volume":"133","author":"Miller","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189721_bb0670","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41698-025-00920-x","article-title":"Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy","volume":"9","author":"Zhao","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0675","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1002\/1878-0261.13657","article-title":"Microglia and macrophages in glioblastoma: landscapes and treatment directions","volume":"18","author":"Solomou","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189721_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2025.1612087","article-title":"Photobleaching alters the morphometric analysis of fluorescently labeled neurons and microglial cells","volume":"31","author":"Polg\u00e1r","year":"2025","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbcan.2026.189721_bb0685","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.3390\/ijms222413382","article-title":"The eclectic nature of glioma-infiltrating macrophages and microglia","volume":"22","author":"Arrieta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189721_bb0690","first-page":"1","article-title":"Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition","author":"Xu","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189721_bb0695","article-title":"Tumor-associated microglia and macrophages in glioblastoma: from basic insights to therapeutic opportunities","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:11:46Z","timestamp":1790863906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":139,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001939"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189721","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage-mesenchymal crosstalk in recurrent glioblastoma: a perspective for therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189721"}}